Health
New drug candidate to fight COVID-19 – Goondiwindi Argus
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.
Its…
-
General18 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News18 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News17 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General20 hours agoBack-to-back rate cuts tipped when Reserve Bank meets